论文部分内容阅读
目的:分析慢性肾小球肾炎患者行贝那普利疗法的临床效果。方法:将2011年8月-2014年10月我院接收慢性肾小球肾炎患者80例作为对象,按治疗意愿分成不同疗法组:对照组(氨氯地平)、研究组(贝那普利),治疗后评估效果。结果:疾病治疗后,研究组缓解39例,占比97.5%,高于75.0%的对照组,有区别。结论:临床针对慢性肾小球肾炎患者行贝那普利疗法作用突出,可缓解病症,预防不良反应,值得借鉴。
Objective: To analyze the clinical effect of benazepril therapy in patients with chronic glomerulonephritis. Methods: From August 2011 to October 2014, 80 patients with chronic glomerulonephritis admitted to our hospital were divided into different treatment groups according to the intention of treatment: control group (amlodipine), research group (benazepril) , After treatment to assess the effect. Results: After the disease was treated, the study group alleviated 39 cases, accounting for 97.5%, higher than 75.0% of the control group, there are differences. Conclusion: The clinical effect of benazepril in patients with chronic glomerulonephritis is prominent, which can alleviate the symptoms and prevent adverse reactions and is worth learning from.